CD44 and breast carcinoma: It has also been demonstrated that PD-L1 was highly expressed on CD44+ CSCs compared to CD44− non-CSCs in head and neck squamous cell carcinoma (HNSCC) [65] and regulates stemness in breast cancer [71].